Javelin Pharmaceuticals, Inc. (JAV)

CAPS Rating:

The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.

View Ticker Page (JAV)

Results 1 - 10 of 31 : 1 2 3 4

Recs

4

Avatar cut2qr (< 20) Submitted: 3/29/07 1:58 AM : Start Price: $6.00 JAV Score: 37.09

Three drugs for post operative pain relief in phase 3 trials due to report next 3mo with one Wall Street pro saying a "transforming event" is around the corner. Sound's good BUT- 1st candidate is an injectable NSAID (Dyloject) that has been availble ...

Report this Post Replies: 1 | Reply | Permalink

Recs

3

Avatar vanamonde (99.96) Submitted: 9/14/07 2:13 AM : Start Price: $5.65 JAV Score: -36.28

Found this stock on caps, scanning through the recent picks of top Wall St. players. Fortis rated in outperform in late July.

Javelin has three product candidates in pipeline, all seemingly in good shape: Dylolect, Rylomine and PMI-150 for which the...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar jayisviking (50.60) Submitted: 1/30/07 5:09 PM : Start Price: $5.05 JAV Score: -32.35

Big things about to happen

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar ESTES27112 (26.06) Submitted: 5/16/08 5:01 PM : Start Price: $3.20 JAV Score: -15.10

This stock has been bludgeoned, but has now found and bottom and with 3 drugs in phase 3, this company could see profits within 2 years.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar ethanbryson (< 20) Submitted: 5/09/08 10:35 AM : Start Price: $2.65 JAV Score: -6.14

The market for pain management drugs is enormous and continues to grow. Each of the three products (one of which is already approved and on the market in Europe) this company is bringing to market is a reformulation of an existing drug with a proven ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar fooluser17 (96.97) Submitted: 1/10/08 1:54 PM : Start Price: $3.63 JAV Score: -21.79

Usually I stay away from pharmaceuticals, but with Fortis giving it the green light and with the drugs they have ready to come out, plus the stock price (gives "nowhere to go but up" a whole new meaning)...seems like a safe bet without much $ to lose...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar zzlangerhans (98.66) Submitted: 10/21/07 4:15 AM : Start Price: $4.87 JAV Score: -28.65

I'm a little uncomfortable with this pick because there's so little objective commentary about the company. However, the three major products in the pipeline are significantly advanced and have high likelihood of eventual FDA approval and marketabili...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar tonysaw1 (< 20) Submitted: 5/20/07 3:20 PM : Start Price: $6.63 JAV Score: -35.38

With Javelins having three drugs in stage three trials and one of them (Dyloject) likely to be aproved by summer,there is some great momentum starting to build with this stock and with Rylomine,the nasel form of morphine likely to advance through sta...

Report this Post Replies: 0 | Reply | Permalink